Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Vazquez

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Hematology (Amsterdam, Netherlands)|February 25, 2016
More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpuraAlberto Vazquez-Mellado, Myrna Pequeño-Luévano, Olga Graciela Cantu-Rodriguez, et al.
Molecular Oncology|August 2, 2024
A novel TAp73-inhibitory compound counteracts stemness features of glioblastoma stem cellsJavier Villoch-Fernandez, Nicole Martínez-García, Marta Martín-López, et al.
Bone Marrow Transplantation|May 14, 2021
The paradox of haematopoietic cell transplant in Latin AmericaGregorio Jaimovich, Robert Peter Gale, Ignacio Hanesman, et al.
Transplantation and Cellular Therapy|November 3, 2025
Barriers to Allogeneic Hematopoietic Cell Transplantation in the Haploidentical Era: A Multicenter Intent-to-Transplant Analysis in a Middle-Income CountryYadith Karina López-García, Christianne Bourlon-De Los Rios, Perla Rocio Colunga-Pedraza, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Hematology (Amsterdam, Netherlands)|February 25, 2016
More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpuraAlberto Vazquez-Mellado, Myrna Pequeño-Luévano, Olga Graciela Cantu-Rodriguez, et al.
Molecular Oncology|August 2, 2024
A novel TAp73-inhibitory compound counteracts stemness features of glioblastoma stem cellsJavier Villoch-Fernandez, Nicole Martínez-García, Marta Martín-López, et al.
Bone Marrow Transplantation|May 14, 2021
The paradox of haematopoietic cell transplant in Latin AmericaGregorio Jaimovich, Robert Peter Gale, Ignacio Hanesman, et al.
Transplantation and Cellular Therapy|November 3, 2025
Barriers to Allogeneic Hematopoietic Cell Transplantation in the Haploidentical Era: A Multicenter Intent-to-Transplant Analysis in a Middle-Income CountryYadith Karina López-García, Christianne Bourlon-De Los Rios, Perla Rocio Colunga-Pedraza, et al.
Pageof 4